We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+4.11%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$55.6B
AUM Growth
+$1.9B
(+3.5%)
Cap. Flow
+$37.5M
Cap. Flow
% of AUM
0.07%
Top 10 Holdings %
Top 10 Hldgs %
29.69%
Holding
1,520
New
84
Increased
535
Reduced
457
Closed
72
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$178M |
| 2 |
Amazon
AMZN
|
+$105M |
| 3 |
Home Depot
HD
|
+$97.5M |
| 4 |
Sherwin-Williams
SHW
|
+$80M |
| 5 |
Ferrovial N.V. Ordinary Shares
FER
|
+$61.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$477M |
| 2 |
CVS Health
CVS
|
+$83M |
| 3 |
Sysco
SYY
|
+$81.2M |
| 4 |
Ball Corp
BALL
|
+$62.5M |
| 5 |
Citigroup
C
|
+$50.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.44% |
| 2 | Healthcare | 15.78% |
| 3 | Financials | 9.7% |
| 4 | Consumer Discretionary | 9.52% |
| 5 | Industrials | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Supernus Pharmaceuticals
SUPN
$2.74B
| $595K | ﹤0.01% |
22,200
| – | – |
|
977
Chord Energy
CHRD
$7.58B
| $590K | ﹤0.01% |
3,557
+3,142
| +757% | +$558K |
|
978
KB Financial Group
KB
$42.4B
| $590K | ﹤0.01% |
10,687
| – | – |
|
979
Cleveland-Cliffs
CLF
$7.13B
| $585K | ﹤0.01% |
39,171
-947
| -2% | -$17K |
|
980
Kontoor Brands
KTB
$4.27B
| $583K | ﹤0.01% |
8,904
| – | – |
|
|
BCYC
981
Bicycle Therapeutics
BCYC
$288M
| $582K | ﹤0.01% |
30,000
| – | – |
|
|
AGR
982
DELISTED
Avangrid, Inc.
AGR
| $574K | ﹤0.01% |
16,221
-42,147
| -72% | -$1.52M |
|
983
Tenet Healthcare
THC
$20.9B
| $570K | ﹤0.01% |
4,119
+1,351
| +49% | +$163K |
|
984
Fulcrum Therapeutics
FULC
$286M
| $568K | ﹤0.01% |
60,000
| – | – |
|
985
Syndax Pharmaceuticals
SNDX
$1.82B
| $564K | ﹤0.01% |
28,300
| – | – |
|
|
AAT
986
American Assets Trust
AAT
$1.38B
| $563K | ﹤0.01% |
25,559
-9,620
| -27% | -$207K |
|
987
Protagonist Therapeutics
PTGX
$9.71B
| $555K | ﹤0.01% |
15,800
| – | – |
|
988
Huntington Ingalls Industries
HII
$13B
| $552K | ﹤0.01% |
2,308
+103
| +5% | +$26.8K |
|
989
Empire State Realty Trust
ESRT
$803M
| $551K | ﹤0.01% |
63,450
| – | – |
|
990
Nice
NICE
$6.01B
| $549K | ﹤0.01% |
3,263
-7,500
| -70% | -$1.54M |
|
991
Westlake Corp
WLK
$10.1B
| $542K | ﹤0.01% |
3,721
+203
| +6% | +$31.2K |
|
|
BELFB
992
Bel Fuse Inc Class B
BELFB
$4.1B
| $533K | ﹤0.01% |
8,287
| – | – |
|
993
Mitek Systems
MITK
$837M
| $529K | ﹤0.01% |
+46,438
| New | +$595K |
|
994
Coca-Cola Consolidated
COKE
$12.4B
| $520K | ﹤0.01% |
4,880
| – | – |
|
|
EXE
995
Expand Energy Corp
EXE
$22.6B
| $520K | ﹤0.01% |
6,366
+292
| +5% | +$25.8K |
|
996
Diamondrock Hospitality Co
DRH
$2.48B
| $518K | ﹤0.01% |
63,235
| – | – |
|
997
Zai Lab
ZLAB
$2.65B
| $518K | ﹤0.01% |
30,000
-6,648
| -18% | -$117K |
|
998
Curtiss-Wright
CW
$25.6B
| $515K | ﹤0.01% |
1,893
+161
| +9% | +$43K |
|
999
Legend Biotech
LEGN
$4B
| $514K | ﹤0.01% |
11,572
+1,792
| +18% | +$82.7K |
|
1000
HNI Corp
HNI
$3.54B
| $513K | ﹤0.01% |
11,514
| – | – |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q2 2024 Portfolio in Review
As of Q2 2024, DekaBank Deutsche Girozentrale held 1,520 positions worth $55.6B, up 3.5% from $53.7B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
DekaBank Deutsche Girozentrale's Q2 2024 filing shows 84 new, 535 increased, 457 reduced and 72 closed positions. Its largest new stake was Ferrovial N.V. Ordinary Shares: 1,554,416 shares worth $59.4M. The largest sale was NVIDIA, an estimated $477M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
- DekaBank Deutsche Girozentrale's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 1,554,416 shares worth $59.4M.
- DekaBank Deutsche Girozentrale added most to Apple in Q2 2024, an estimated $178M increase.
- DekaBank Deutsche Girozentrale's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $477M.
- DekaBank Deutsche Girozentrale fully exited Interparfums in Q2 2024, selling an estimated $4.49M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 30% of its $55.6B portfolio in Q2 2024.
- DekaBank Deutsche Girozentrale opened 84 new positions and closed 72 in Q2 2024.
- DekaBank Deutsche Girozentrale's portfolio value rose 3.5% quarter-over-quarter to $55.6B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2024, filed 8 Aug 2024.